South Korea says North Korea tried to hack its coronavirus vaccine developers

South Korea’s intelligence agency foiled North Korean attempts to hack into South Korean companies developing coronavirus vaccines, lawmakers said on Friday. Ha Tae-keung, a member of the parliamentary intelligence committee, … Read More

Two shots. A waiting period. Why the coronavirus vaccine won’t be a quick fix

News about a potential coronavirus vaccine has, predictably, prompted excitement from a lockdown-weary world. But experts say: Not so fast. “It’s completely understandable to have enthusiasm, but this is not … Read More

Canada could get multiple coronavirus vaccines. Experts say there are unique challenges

Vaccine-related news has dominated the waterfall of coronavirus headlines in recent weeks and so far, it’s been refreshingly positive. Multiple COVID-19 vaccines could be approved in the coming months, and … Read More

AstraZeneca’s coronavirus vaccine produces strong immune response in older adults

AstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas. … Read More

Pfizer launches pilot delivery program for potential coronavirus vaccine in 4 states

Pfizer has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements. … Read More

Canada’s coronavirus cases exceed 300,000

Canada surpassed 300,000 confirmed cases of the novel coronavirus on Monday, marking yet another grim milestone for a country grappling with a worsening second wave. As of 6:20 p.m. ET., … Read More

Janssen to begin final stage trials of coronavirus candidate in the U.K.

Britain will be the first country to run final stage trials of an experimental coronavirus vaccine being developed by the pharmaceutical company Janssen, a subsidiary of Johnson & Johnson. Scientists … Read More

Moderna’s coronavirus vaccine is 94.5% effective, company says

For the second time this month, there’s promising news from a COVID-19 vaccine candidate: Moderna said Monday its shots provide strong protection, a dash of hope against the grim backdrop … Read More

Bolsonaro claims ‘victory’ as Chinese coronavirus vaccine trial halted in Brazil

Brazil‘s health regulator has suspended a clinical trial for China‘s Sinovac coronavirus vaccine citing a severe adverse event, delighting President Jair Bolsonaro, who has criticized it for lacking credibility amid … Read More

Canadian company sees positive results in early coronavirus vaccine tests

Medicago says it has received promising early test results for its plant-derived vaccine for the novel coronavirus. The Quebec City-based company says interim results of a Phase 1 clinical trial … Read More

Pfizer’s coronavirus vaccine: Here’s what experts are saying about the new data

Pfizer released an early snapshot of its Phase 3 trials for its coronavirus vaccine on Monday, and said the results look promising with data suggesting it’s 90 per cent effective … Read More

Pfizer’s coronavirus vaccine may be 90% effective, early data suggests

Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file … Read More

First COVID-19 vaccines will face distribution challenges in new year, Trudeau says

Prime Minister Justin Trudeau says some COVID-19 vaccine candidates expected in the new year will pose significant logistical and distribution challenges. Trudeau says he hopes a viable vaccine will be … Read More

AstraZeneca resumes U.S. coronavirus vaccine trial, Johnson & Johnson to follow

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the … Read More

Coronavirus vaccine: Pfizer may ask for emergency approval in late November

Pfizer said on Friday it may file for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, making it unlikely a vaccine will be … Read More

Eli Lilly to resume some coronavirus antibody-drug trials after safety concerns

Eli Lilly & Co on Wednesday said that other trials of its experimental COVID-19 antibody-drug will continue apace after it paused one ongoing trial of the drug, citing safety concerns. … Read More

World Bank approves $12 billion to fund coronavirus vaccines, tests and treatments

The World Bank has approved $12 billion in financing to help developing countries buy and distribute coronavirus vaccines, tests, and treatments, aiming to support the vaccination of up to 1 … Read More

Coronavirus vaccine trials: Pfizer to include participants as young as 12

Pfizer Inc will enroll participants as young as 12 in its large, late-stage COVID-19 vaccine trial to understand how it works in a wider age group. Read more: White House blocks new … Read More

Johnson & Johnson pauses coronavirus vaccine trials after ‘unexplained illness’

Johnson & Johnson has temporarily paused its clinical trials for a potential novel coronavirus vaccine after an “unexplained illness” in a study participant, the company said Monday. In a statement … Read More

U.S. official expects coronavirus vaccine to arrive in January, contradicting Trump

A Trump administration official leading the response to the coronavirus pandemic says the U.S. can expect delivery of a vaccine starting in January 2021, despite statements from the president that inoculations could … Read More

Scientist behind Russia coronavirus vaccine defends ‘wartime’ rollout during trial

Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to … Read More

Canada signs deal with VBI Vaccines to develop coronavirus candidate by 2022

VBI Vaccines Inc said on Monday it had entered into an agreement with Canada to develop a potential vaccine for COVID-19 by 2022 through mid-stage trials conducted exclusively in the … Read More

AstraZeneca to resume coronavirus vaccine trial after unexplained illness in U.K.

Clinical trials testing a potential COVID-19 vaccine developed by AstraZeneca and the University of Oxford are set to resume after a six-day pause due to “potentially unexplained illness” in the … Read More

Why a pause on AstraZeneca’s coronavirus vaccine trial isn’t entirely bad news

The world is waiting with bated breath for a coronavirus vaccine. So when AstraZeneca, a frontrunner in Phase 3 of global trials, unexpectedly hit pause on its study due to … Read More

Canada to secure up to 76 million coronavirus vaccine doses from Novavax

Novavax Inc. says it has reached an agreement with the Canadian government to supply up to 76 million doses of its possible vaccine for COVID-19. The company announced the agreement … Read More

Canada secures 2 new deals for possible COVID-19 vaccines

Canada has inked two additional deals with companies working on a possible vaccine for COVID-19. The two agreements include 76 million doses of Novavax Inc.’s vaccine candidate and 38 million … Read More

Two people in Europe reinfected with coronavirus months after 1st illness

Two European patients are confirmed to have been re-infected with the coronavirus, raising concerns about people’s immunity to the virus as the world struggles to tame the pandemic. The cases, … Read More

1st coronavirus reinfection case reported by researchers in Hong Kong

A Hong Kong man who recovered from COVID-19 was infected again four-and-a-half months later in the first documented instance of human re-infection, researchers at the University of Hong Kong said … Read More

Coronavirus antibodies decay fast, but that doesn’t mean protection is gone: study

New research suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness, but that doesn’t mean protection … Read More

Potential coronavirus vaccine has ‘right sort of immune response’ in trial: scientist 

A leading scientist behind the University of Oxford’s potential COVID-19 vaccine said on Wednesday the team has seen the right sort of immune response in trials but declined to give … Read More

2 years of coronavirus pandemic is ‘best-case scenario,’ doctor warns

It’s been almost four months since the World Health Organization (WHO) declared the coronavirus a pandemic — and now experts say it could be years before we’re out of the … Read More

China green lights coronavirus vaccine candidate for use on its military

China’s military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and showed some … Read More

Coronavirus drug remdesivir to cost $2,340 per patient in the U.S.

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government … Read More

Over 10,000 to receive potential COVID-19 vaccine in U.K. as studies advance

British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works. Last … Read More

Over 10,000 to receive potential COVID-19 vaccine in U.K. as tests expand

British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works. Last … Read More

Moderna’s coronavirus vaccine shows signs of success in early-stage trial

Moderna Inc said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients, sending … Read More

Conspiracies are spreading over coronavirus vaccines before one even exists

A coronavirus vaccine is still months or years away, but groups that peddle misinformation about immunizations are already taking aim, potentially eroding confidence in what could be humanity’s best chance to defeat … Read More